Candel Therapeutics (CADL) shares were down about 15% in recent Wednesday trading after BofA Securities lowered its rating on the stock to neutral from buy.
Trading volume stood at 2 million shares compared with a daily average of about 833,293 shares.
Price: 5.01, Change: -0.86, Percent Change: -14.59
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.